Works matching IS 19427603 AND DT 2024 AND VI 16 AND IP 12

Results: 17

EMCDDA framework and practical guidance for naming cathinones.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1409, doi. 10.1002/dta.3662

By:

Pulver, Benedikt;
Fischmann, Svenja;
Gallegos, Ana;
Christie, Rachel

Publication type:

Article

Dried blood spots via remote testing as a possible future application in the doping control process.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1558, doi. 10.1002/dta.3679

By:

Trinks, Stefan;
Braun, Kristina;
Gotzmann, Andrea;
Bunthoff, Eva;
Mueser, Dominic

Publication type:

Article

Analysing and quantifying chronic stress‐associated endogenous steroids in hair samples.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1564, doi. 10.1002/dta.3678

By:

Grafinger, Katharina Elisabeth;
Kassis, Wassilis;
Favre, Céline A.;
Aksoy, Dilan;
Gaugler, Stefan

Publication type:

Article

Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti‐doping rule violation. IV. Case example with mesterolone.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1575, doi. 10.1002/dta.3676

By:

Kintz, Pascal;
Gheddar, Laurie

Publication type:

Article

Obituary Don H. Catlin.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1509, doi. 10.1002/dta.3673

By:

Thevis, Mario

Publication type:

Article

Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1578, doi. 10.1002/dta.3680

By:

Chen, Rui‐Jia;
Zhang, Zi‐hua;
Yang, Shenglan;
Yu, Shu‐chen;
Wang, Jun‐chang;
Liao, Ping‐yong;
Qiu, Ting‐ting;
Xiao, Lu;
Xue, Shang;
Chen, Hong;
Shao, Wen‐bin;
Hu, Jian‐wen;
Lan, Yun;
Chen, Xi‐long;
Xu, Yue;
Zhou, Tian‐meng;
Zhao, Xue‐jun;
Liu, Wen‐bin

Publication type:

Article

Determination of higenamine in common natural spices by ultrahigh‐performance liquid chromatography–tandem mass spectrometry.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1537, doi. 10.1002/dta.3672

By:

Du, Jinming;
Li, Xuefen;
Tian, Wenyi;
Guo, Chengjun

Publication type:

Article

Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1544, doi. 10.1002/dta.3668

By:

Bergh, Marianne Skov‐Skov;
Bogen, Inger Lise;
Grafinger, Katharina Elisabeth;
Huestis, Marilyn A.;
Øiestad, Åse Marit Leere

Publication type:

Article

The origin of 2,5‐dimethoxy‐4‐methylamphetamine (DOM, STP).

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1496, doi. 10.1002/dta.3667

By:

Trout, Keeper;
Daley, Paul F.

Publication type:

Article

Homologous blood transfusion and doping: Where are we now?

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1479, doi. 10.1002/dta.3666

By:

Marchand, Alexandre;
Ericsson, Magnus

Publication type:

Article

Gene doping detection in the era of genomics.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1468, doi. 10.1002/dta.3664

By:

Li, Ruihong;
Su, Peipei;
Shi, Yi;
Shi, Hui;
Ding, Shengqian;
Su, Xianbin;
Chen, Peijie;
Wu, Die

Publication type:

Article

Reliability of roadside oral fluid testing devices for ∆9‐tetrahydrocannabinol (∆9‐THC) detection.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1528, doi. 10.1002/dta.3669

By:

Scherer, Juliana Nichterwitz;
Vasconcelos, Mailton;
Dalanhol, Carolina Silveira;
Govoni, Bruna;
dos Santos, Bruno Pereira;
Borges, Gabriela Ramos;
de Gouveia, Giovanna Cristiano;
Viola, Patrícia Pacheco;
Carlson, Renato Luiz Romera;
Martins, Aline Franco;
Costa, Jose Luiz;
Huestis, Marilyn A.;
Pechansky, Flavio

Publication type:

Article

Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1510, doi. 10.1002/dta.3660

By:

Levernæs, Maren Christin Stillesby;
Solheim, Sara A.;
Broderstad, Lillian;
Zandy, Essa;
Mørkeberg, Jakob;
Dehnes, Yvette

Publication type:

Article

Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1487, doi. 10.1002/dta.3658

By:

Suraev, Anastasia;
McCartney, Danielle;
Kevin, Richard;
Gordon, Rebecca;
Grunstein, Ronald R.;
Hoyos, Camilla M.;
McGregor, Iain S.

Publication type:

Article

Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti‐ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs.

Published in:

Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1436, doi. 10.1002/dta.3655

By:

Jędrejko, Karol;
Catlin, Oliver;
Stewart, Timothy;
Muszyńska, Bożena

Publication type:

Article

Cover Picture.

Published in:: Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1, doi. 10.1002/dta.3513
Publication type:: Article

Issue Information.

Published in:: Drug Testing & Analysis, 2024, v. 16, n. 12, p. 1403, doi. 10.1002/dta.3512
Publication type:: Article

Works matching IS 19427603 AND DT 2024 AND VI 16 AND IP 12

EMCDDA framework and practical guidance for naming cathinones.

Dried blood spots via remote testing as a possible future application in the doping control process.

Analysing and quantifying chronic stress‐associated endogenous steroids in hair samples.

Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti‐doping rule violation. IV. Case example with mesterolone.

Obituary Don H. Catlin.

Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA.

Determination of higenamine in common natural spices by ultrahigh‐performance liquid chromatography–tandem mass spectrometry.

Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine.

The origin of 2,5‐dimethoxy‐4‐methylamphetamine (DOM, STP).

Homologous blood transfusion and doping: Where are we now?

Gene doping detection in the era of genomics.

Reliability of roadside oral fluid testing devices for ∆<sup>9</sup>‐tetrahydrocannabinol (∆<sup>9</sup>‐THC) detection.

Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers.

Detection of Δ<sup>9</sup>‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil.

Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti‐ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs.

Cover Picture.

Issue Information.